Letermovir prophylaxis reduces the risk for CMV reactivation after allogeneic stem cell transplantation

被引：0
|
作者：
Koch, K. [1 ]
Herhaus, P. [1 ]
Osswald, L. [1 ]
Braitsch, K. [1 ]
Bassermann, F. [1 ]
Verbeek, M. [1 ]
机构：
[1] Tech Univ Munich, Munich, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V639
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [31] CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality
    Eberhardt, Kirsten Alexandra
    Jung, Verena
    Knops, Elena
    Heger, Eva
    Wirtz, Maike
    Steger, Gertrud
    Kaiser, Rolf
    Affeldt, Patrick
    Holtick, Udo
    Klein, Florian
    Scheid, Christof
    Di Cristanziano, Veronica
    BONE MARROW TRANSPLANTATION, 2023, 58 (06) : 639 - 646
  • [32] CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality
    Kirsten Alexandra Eberhardt
    Verena Jung
    Elena Knops
    Eva Heger
    Maike Wirtz
    Gertrud Steger
    Rolf Kaiser
    Patrick Affeldt
    Udo Holtick
    Florian Klein
    Christof Scheid
    Veronica Di Cristanziano
    Bone Marrow Transplantation, 2023, 58 : 639 - 646
  • [33] Valganciclovir for the prophylaxis of early cytomegalovirus (CMV) infection after allogeneic stem cell transplantation
    Bachier, C
    Shaughnessy, P
    Wall, D
    Grimley, M
    Carrum, G
    Freytes, C
    Callander, N
    Walsh, T
    LeMaistre, CF
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 90 - 91
  • [34] CMV-Reactivation after allogeneic Bone Marrow Transplantation Approval of the Drug Letermovir recommended in the EU
    不详
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2017, 44 (06) : 430 - 430
  • [35] IMMUNE POPULATIONS PREDICT CONTROL OF CMV REACTIVATION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Diaz-Fernandez, Paula
    Garcia de Soria, Valle Gomez
    Sevilla-Montero, Javier
    Marcos-Jimenez, Ana
    Serra Lopez-Matencio, Jose Maria
    Cardenoso, Laura
    Figuera Alvarez, Angela
    de la Camara, Rafael
    Munoz-Calleja, Cecilia
    BONE MARROW TRANSPLANTATION, 2024, 59 : 431 - 431
  • [36] CMV and EBV Reactivation after Allogeneic Transplantation
    Butler, Andrew
    Thurston, Andrew
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S244 - S244
  • [37] Single center real-world data on Letermovir prophylaxis for cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation
    Derigs, P.
    Schubert, M. -L.
    Schnitzler, P.
    Mueller-Tidow, C.
    Dreger, P.
    Schmitt, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 173 - 173
  • [38] Application of CMV-IVIg as prophylaxis against cytomegalovirus reactivation in allogeneic hematopoietic stem cell transplantation patients
    Cui, Jiaqi
    Zhou, Yuhang
    Zhao, Kui
    Li, Xudong
    Zhang, Hanyue
    Zhang, Xiangzhong
    Sun, Yanling
    Long, Bing
    CLINICAL TRANSPLANTATION, 2024, 38 (04)
  • [39] The Impact of Letermovir Prescribing on the Rate of Cytomegalovirus Reactivation Following Allogeneic Stem Cell Transplantation
    Smith, Siobhan
    Duncan, Nick
    Ricketts, Laura
    O'Neill, Jessica
    Gautama, Brijesh
    Ibrahim, Abeer
    Jones, Ceri H.
    Kempshall, Emma
    Ingram, Wendy
    Wilson, Keith
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 372 - 373
  • [40] Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study
    Marc Brusosa
    Sonia Ruiz
    Inés Monge
    María Teresa Solano
    Laura Rosiñol
    Jordi Esteve
    Enric Carreras
    M. Ángeles Marcos
    Gisela Riu
    Esther Carcelero
    Carmen Martinez
    Francesc Fernández-Avilés
    Montserrat Rovira
    María Suárez-Lledó
    María Queralt Salas
    Annals of Hematology, 2024, 103 : 609 - 621
12345